| http://www.w3.org/ns/prov#value | - A further list and description of these risks, uncertainties and other factors can be ...Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction... ability to protect our intellectual property, our ability to continue to list our common stock on the NASDAQ Global Market or to list our common stock on the NASDAQ Capital Market and those other fact
|
